We intend to focus on opportunities that capitalize on the expertise and ability of our team, particularly our executive officers, to identify, acquire and operate a business in the broadly defined sustainability industry. This industry includes, but is not limited to, energy and power (with a focus on renewable energy, biofuels and energy storage), resource […]

We will focus on companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. We intend to capitalize on the unique mix of experience and highly complementary capabilities of our co-founders, Clive Meanwell and Ian Read, as well as our management team, in leading, operating and strategically positioning […]

(IPOScoop has No Call on this initial public offering. Please see this statement in the prospectus: “Until recently, our Ordinary Shares traded on the Australian Securities Exchange operated by ASX Ltd. (or ASX), under the symbol “GMV.” On October 22, 2020, our Ordinary Shares were voluntarily delisted from the ASX. We have been approved to […]

We are a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines, and to support research on human diseases. Our more than 5,000 customers as of Sept. 30, 2020 include the top 20 global biopharmaceutical companies ranked by research and development expenditures according to industry consultants, […]

While we may pursue a business combination target in any business or industry, we intend to focus on global companies in telecom, media and technology (“TMT”), healthcare, fintech and consumer sectors with compelling Asian growth potential. We believe our management team and directors have the relevant skills and experience to identify companies that can best […]

We intend to focus our search on identifying a prospective target that can benefit from our operational expertise in the technology, media and telecommunications (“TMT”) industry, including the wireless communications industry.    Our founder and chairman, Charles W. Ergen, is one of the most prominent and respected figures in the TMT industry with extensive experience […]

We intend to focus our search for a target business in the consumer sector. We believe our management team is well suited to identify opportunities that have the potential to generate attractive risk-adjusted returns for our shareholders, although we may pursue a business combination opportunity in any business or industry. Our company was founded by senior […]

We intend to focus our search for a target business in the energy industry in North America. Each member of our management team has nearly 30 years average experience in the energy industry: *J. Douglas Ramsey, Ph.D., our chairman and CEO, was the president and CFO of Saddle Operating, LLC, a private acquisition and production […]

It is our intention to pursue prospective targets that are focused on technologies and products related to sustainable plant-based food and beverages, alternative protein, and ingredients. More specifically, our target market includes companies that use plant-based, cell-based or precise fermentation technologies to develop food products that eliminate animals from the food supply chain. (Note: The […]

We intend to focus our search on “omnichannel” businesses — technology-enabled cross-channel retail and consumer services — including the direct-to-consumer (“DTC”) / e-commerce retail, consumer healthcare, consumer marketplaces, consumer services and related sectors in North America with enterprise values from $1 billion to $2.5 billion. (Note: This IPO was downsized again at pricing: 20 million units priced at $10. The size of […]